Tag: pharmaceutical industry

Blog Posts (3)

April 20, 2014

Astellas to pay $7.3M in drug-marketing settlement

[Bloomberg] — A unit of Japanese drugmaker Astellas Pharma will pay the U.S. government $7.3 million to resolve claims it illegally marketed its antifungal drug Mycamine for children before that use was approved. The U.S. Department of Justice says Astellas’ illegal marketing took place between 2005 and 2010. Mycamine was approved for use in adults […]
April 18, 2014

Surge in Narcotic Prescriptions for Pregnant Women

[New York Times] Doctors are prescribing opioid painkillers to pregnant women in astonishing numbers, new research shows, even though risks to the developing fetus are largely unknown.Of 1.1 million pregnant women enrolled in Medicaid nationally, nearly 23 percent filled an opioid prescription in 2007, up from 18.5 percent in 2000, according to a study published last […]
April 9, 2014

US jury orders Takeda, Eli Lilly to pay $9 billion in damages over Actos

[FirstWordPharma] A US jury ordered Takeda and Eli Lilly to pay a combined $9 billion in punitive damages after finding that the companies concealed the cancer risks associated with the diabetes therapy Actos (pioglitazone). The jury also awarded compensatory damages to the plaintiff of nearly $1.5 million in the first federal lawsuit related to the […]

Published Articles (2)

American Journal of Bioethics: Volume 8 Issue 8 - Aug 2008

Conflicts of Interest in Bioethics: A Response to Our Critics

American Journal of Bioethics: Volume 8 Issue 8 - Aug 2008

Who Is Buying Bioethics Research?

News (7)

June 21, 2012 1:12 pm

Health Groups Criticize Allergy Drug Promotion (New York Times)

Public health advocates on Wednesday accused the drug company Merck of improperly marketing an over-the-counter allergy medicine directly to children using animated characters from the movie “Madagascar 3: Europe’s Most Wanted.”

June 9, 2012 9:18 pm

Obama Was Pushed by Drug Industry, E-Mails Suggest (New York Times)

After weeks of talks, drug industry lobbyists were growing nervous. To cut a deal with the White House on overhauling health care, they needed to be sure that President Obama would stop a proposal intended to bring down medicine prices.

May 9, 2012 10:15 am

Senate Inquiry Into Painkiller Makers’ Ties (New York Times)

Two senior senators said on Tuesday that they had opened an investigation into financial ties between producers of prescription painkillers and pain experts, patient advocacy groups and organizations that set guidelines on how doctors use the drugs.

May 4, 2012 1:35 pm

FDA recommended to continue monitoring drugs' safety after approval (News-Medical)

The FDA-which asked the IOM to “convene a committee to evaluate the scientific and ethical issues involved in conducting studies of the safety of approved drugs”-already collects much of the suggested information, but the data are scattered across multiple records rather than amassed in one central location. “Decentralized records make it difficult for physicians, policy makers and consumers to easily assess information about risks and benefits that accrue over time,” Faden notes.

May 2, 2012 3:38 pm

China, Bioethics & The Wild West: Joe Explains (Pharmalot)

Next fall, the University of Pennsylvania will host a 10-day crash course in Bioethics in China, which some may argue is an oxymoron. The program will actually take place in Beijing and other cities, and include meetings with academics, policy makers and pharma folks, such as expats who work for large drugmakers. The plan is to not only review some of the hot-button issues – corruption, clinical trials, intellectual property and interactions between physicians and patients – but also delve into cultural differences that shape the way business is done there.

April 25, 2012 11:38 am

Drugs firm takes cost conscious doctors to court (The Independent)

Independent experts have condemned the Swiss pharmaceuticals company Novartis for trying to force the NHS to buy an expensive drug to treat patients suffering from a degenerative eye disease, rather than using a cheaper, unlicensed alternative. Novartis is taking four NHS areas in the south of England to a judicial review because they have allowed doctors to prescribe the anti-cancer drug Avastin to treat the wet form of age-related macular degeneration.

April 24, 2012 11:23 am

Dying Mom Posts Video for Compassionate Use; Company Agrees (ABC News)

Social media proved to be one powerful tool for a mother dying of breast cancer and desperate to get a drug that has yet to be approved by the U.S. Food and Drug Administration… Gant, 46, posted the video on YouTube as an attempt to plead with the FDA to allow her to use a trial drug known as pertuzumab under compassionate use. The FDA is expected to approve the drug, developed by Genentech, on June 8. But Gant doesn’t expect to live that long.